Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Change in Account Payables (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Change in Account Payables for 5 consecutive years, with $25000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Change in Account Payables fell 96.64% to $25000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$369000.0, a 137.81% decrease, with the full-year FY2024 number at $3.0 million, up 1014.76% from a year prior.
  • Change in Account Payables was $25000.0 for Q4 2020 at Forte Biosciences, up from -$1.4 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $3.1 million in Q3 2018 to a low of -$1.4 million in Q3 2020.
  • A 5-year average of $137850.0 and a median of $50500.0 in 2016 define the central range for Change in Account Payables.
  • Peak YoY movement for Change in Account Payables: skyrocketed 8873.53% in 2018, then plummeted 1352.78% in 2020.
  • Forte Biosciences' Change in Account Payables stood at -$278000.0 in 2016, then surged by 389.21% to $804000.0 in 2017, then crashed by 237.69% to -$1.1 million in 2018, then soared by 167.21% to $744000.0 in 2019, then tumbled by 96.64% to $25000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Change in Account Payables are $25000.0 (Q4 2020), -$1.4 million (Q3 2020), and $1.9 million (Q2 2020).